控制非糖尿病脓毒症患者的血糖变异性：迈向重症监护精准化的一步。
Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care.
作者信息
Prakash Jay, Vaibhaw Vishal, Saran Khushboo
机构信息
Department of Critical Care Medicine, Rajendra Institute of Medical Sciences (RIMS), Ranchi, Jharkhand, India.
Department of Emergency Medicine, All India Institute of Medical Sciences, Patna, Bihar, India.
出版信息
Indian J Crit Care Med. 2025 Jan;29(1):6-7. doi: 10.5005/jp-journals-10071-24880. Epub 2024 Dec 30.
Abstract
Prakash J, Vaibhaw V, Saran K. Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care. Indian J Crit Care Med 2025;29(1):6-7.
摘要
普拉卡什·J、维巴夫·V、萨兰·K。控制非糖尿病脓毒症患者的血糖变异性：迈向重症监护精准化的一步。《印度重症监护医学杂志》2025年；29(1)：6 - 7。
相似文献
1
Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care.控制非糖尿病脓毒症患者的血糖变异性：迈向重症监护精准化的一步。
Indian J Crit Care Med. 2025 Jan;29(1):6-7. doi: 10.5005/jp-journals-10071-24880. Epub 2024 Dec 30.
2
Association of Glycemic Variability with Outcomes in Non-diabetic Sepsis Patients: A Prospective Observational Study.血糖变异性与非糖尿病脓毒症患者预后的相关性：一项前瞻性观察性研究。
Indian J Crit Care Med. 2025 Jan;29(1):27-35. doi: 10.5005/jp-journals-10071-24873. Epub 2024 Dec 30.
3
Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care.控制非糖尿病脓毒症患者的血糖变异性：迈向重症监护精准化的一步。
Indian J Crit Care Med. 2025 Feb;29(2):197. doi: 10.5005/jp-journals-10071-24909.
4
Association between various blood glucose variability-related indicators during early ICU admission and 28-day mortality in non-diabetic patients with sepsis.非糖尿病脓毒症患者入住重症监护病房早期各种血糖变异性相关指标与28天死亡率之间的关联。
Diabetol Metab Syndr. 2025 Jan 20;17(1):22. doi: 10.1186/s13098-025-01580-4.
5
The Sepsis Score Dilemma: Balancing Precision and Utility.脓毒症评分困境：平衡精准性与实用性
Indian J Crit Care Med. 2024 Oct;28(10):906-907. doi: 10.5005/jp-journals-10071-24814. Epub 2024 Sep 30.
6
Nerve Conduction Studies: What an Intensivist should Know?神经传导研究：重症监护医生应该知道什么？
Indian J Crit Care Med. 2022 Jun;26(6):759-760. doi: 10.5005/jp-journals-10071-24229.
7
Effects of Glycemic Variability in Critically Ill Patients with Coronavirus Disease 2019: A Retrospective Observational Study.2019年冠状病毒病危重症患者血糖变异性的影响：一项回顾性观察研究
Indian J Crit Care Med. 2024 Apr;28(4):381-386. doi: 10.5005/jp-journals-10071-24688.
8
Critical Insights into Novel Immunomodulatory Therapy for Sepsis: Evaluating Promise Amidst Limitations.脓毒症新型免疫调节疗法的关键见解：在局限性中评估前景。
Indian J Crit Care Med. 2025 Jan;29(1):90. doi: 10.5005/jp-journals-10071-24847. Epub 2024 Dec 30.
9
Is it Time to Develop an Indian Sepsis-related Mortality Prediction Score?是时候开发一个印度脓毒症相关死亡率预测评分系统了吗？
Indian J Crit Care Med. 2024 Apr;28(4):320-322. doi: 10.5005/jp-journals-10071-24693.
10
Portending Complications in Pediatric Diabetic Ketoacidosis.小儿糖尿病酮症酸中毒的潜在并发症
Indian J Crit Care Med. 2021 Dec;25(12):1339-1340. doi: 10.5005/jp-journals-10071-24064.
引用本文的文献
1
Controlling Glycemic Variability in Non-diabetic Sepsis Patients: A Step toward Precision in Critical Care.控制非糖尿病脓毒症患者的血糖变异性：迈向重症监护精准化的一步。
Indian J Crit Care Med. 2025 Feb;29(2):197. doi: 10.5005/jp-journals-10071-24909.
本文引用的文献
1
Sepsis Biomarkers: Advancements and Clinical Applications-A Narrative Review.脓毒症生物标志物：进展与临床应用——叙述性综述。
Int J Mol Sci. 2024 Aug 19;25(16):9010. doi: 10.3390/ijms25169010.
2
Assessing glycemic variability in critically ill patients: A prospective cohort study comparing insulin infusion therapy with insulin sliding scale.评估危重症患者的血糖变异性：一项比较胰岛素输注治疗与胰岛素滴注疗法的前瞻性队列研究。
Sci Rep. 2024 May 2;14(1):10128. doi: 10.1038/s41598-024-57403-5.
3
Glycemic Variability As a Prognostic Factor for Mortality in Patients With Critical Illness: A Systematic Review and Meta-Analysis.血糖变异性作为危重症患者死亡率的预后因素：一项系统评价和荟萃分析。
Crit Care Explor. 2024 Jan 11;6(1):e1025. doi: 10.1097/CCE.0000000000001025. eCollection 2024 Jan.
4
Acute glycemic variability and risk of mortality in patients with sepsis: a meta-analysis.脓毒症患者的急性血糖变异性与死亡风险：一项荟萃分析
Diabetol Metab Syndr. 2022 Apr 23;14(1):59. doi: 10.1186/s13098-022-00819-8.
5
Glucose Variability: How Does It Work?血糖变异性：它是如何工作的？
Int J Mol Sci. 2021 Jul 21;22(15):7783. doi: 10.3390/ijms22157783.
6
Is intensive glucose control bad for critically ill patients? A systematic review and meta-analysis.强化血糖控制对危重症患者有害吗？一项系统评价和荟萃分析。
Int J Biol Sci. 2020 Mar 12;16(9):1658-1675. doi: 10.7150/ijbs.43447. eCollection 2020.
7
High blood glucose variability is associated with bacteremia and mortality in patients hospitalized with acute infection.高血糖波动与急性感染住院患者的菌血症和死亡率相关。
QJM. 2019 Feb 1;112(2):101-106. doi: 10.1093/qjmed/hcy235.
8
Dysglycemia in the critically ill patient: current evidence and future perspectives.危重症患者的血糖异常：当前证据与未来展望
Rev Bras Ter Intensiva. 2017 Jul-Sep;29(3):364-372. doi: 10.5935/0103-507X.20170054.
9
Continuous glucose monitoring in insulin-treated patients in non-ICU settings.非重症监护病房环境下胰岛素治疗患者的连续血糖监测
J Diabetes Sci Technol. 2014 Sep;8(5):930-6. doi: 10.1177/1932296814546025. Epub 2014 Aug 13.
10
Continuous glucose monitoring: current use and future directions.连续血糖监测：当前的应用和未来方向。
Curr Diab Rep. 2013 Oct;13(5):657-62. doi: 10.1007/s11892-013-0398-4.
Zotero 插件